1Y Annualised Return
▲9.80%
3Y Annualised Return
▲20.44%
5Y Annualised Return
▲26.65%
Norris Medicines Stock Performance
|
|
|
Norris Medicines Company background
Founded in: 1990
Managing director: Vimal D Shah
Norris Medicines Limited was established in September, 1990 as a small scale unit at GIDC Estate, Ankleshwar to manufacture non sterile dosage e.g. tablets, capsules, Liquid Orals, Copical ointments. The Company was subsequently converted into Public Limited Company on March 7, 1992. The unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The Company got into the business in the year 1990. Commercial production of the formulation unit commenced in Nov.91. The production unit expanded to manufacture Sterile dosage in form of Ampoules Vials. The project commence in March 1992. Thereafter, the Company came out with a Public Issue aggregating Rs. 5 Crore in December, 1993 to expand its existing capacity for tablets, capsules, etc, besides diversifying into bulk drugs and setting up an injectables unit. The project costing Rs 14.21 Crore was financed through loans and equity, which got completed in 1995.In 2006, the Company launched Diabetic Cardiac products launched Dental product in 2007 launched New Molecule Tolperisone with Paracetamol tablet in 2012 in 2013, it extended Anti malarial range with Artemether Lumefantrine tablet dry syrup. During the year 201314, the Company undertook the upgradation of Sterile Injectable Plant. The Company is one of the leading Indian manufacturers of Injections and Medicinal formulations. The Company is engaged into Health Care Industry and operate 2 plants situated at GIDC, Ankleshwar, Gujarat. Both plants of the Company are WHO GMP approved. At present, it has renovated the Sterile Injectable Plant and with this the plant is now as per international standards.
As of 5 Sep, 2025, Norris Medicines share price is ₹16.2. The stock opened at ₹16.3 and had closed at ₹16.3 the previous day. During today’s trading session, Norris Medicines share price moved between ₹16.25 and ₹16.31, with an average price for the day of ₹16.28. Over the last 52 weeks, the stock has recorded a low of ₹14.78 and a high of ₹27.74. In terms of performance, Norris Medicines share price has declined by 12% over the past six months and has increased by 9.80% over the last year.
Norris Medicines SIP Return Calculator
Over the past
1 year
3 years
5 years
Total Investment of ₹65,00,000
Would have become ₹68,30,387 (+5.08%)
Daily SIP of ₹25,000 would have become ₹68,30,387 in 1 year with a gain of ₹3,30,387 (+5.08%)
Norris Medicines Fundamental
Market Cap (in crs)
16.31
Face Value
10
Turnover (in lacs)
0.18
Key Metrics
Qtr Change %
41.42% Fall from 52W High
-12.3
Dividend yield 1yr %
0
Norris Medicines Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
16.25
Current Price
5Day EMA
16.40
10Day EMA
16.50
12Day EMA
16.50
20Day EMA
16.70
26Day EMA
16.80
50Day EMA
17.20
100Day EMA
17.60
200Day EMA
17.80
5Day SMA
16.40
10Day SMA
16.30
20Day SMA
16.80
30Day SMA
16.70
50Day SMA
17.20
100Day SMA
17.80
150Day SMA
18.40
200Day SMA
18.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 134 Rs | 191 Rs |
Week Rs | 489 Rs | 595 Rs |
Month Rs | 837 Rs | 994 Rs |
Resistance & Support
16.51
Pivot
Resistance
First Resistance
16.72
Second Resistance
17.12
Third Resistance
17.33
Support
First Support
16.11
Second support
15.90
Third Support
15.50
Relative Strength Index
46.02
Money Flow Index
26.22
MACD
-0.25
MACD Signal
-0.27
Average True Range
1.06
Average Directional Index
16.84
Rate of Change (21)
-6.69
Rate of Change (125)
-14.70
Norris Medicines Peer comparison
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
124.80 | 18.10 | 59.58 | 154 | 120.65 | 5.09% | -6.24% | 36.68% | 70.96% | 262.26% | 0.00% | 0.00 | 40.57 | 1.38 | |
Bacil Pharma Ltd. | - | 35.06 | - | - | - | - | - | - | - | - | - | - | - | - |
24.01 | 12.40 | 17.35 | 46 | 24.45 | -4.80% | 17.01% | -0.25% | -25.48% | 152.74% | 0.00% | 53.15 | 40.57 | 1.31 | |
24.70 | 13.62 | 6.27 | 36.96 | 26.00 | -22.55% | -5.11% | 21.61% | 490.91% | 490.91% | 0.00% | 0.00 | 40.57 | 3.10 | |
37.87 | 19.73 | 8.02 | 45.45 | 36.07 | 27.51% | -11.60% | 129.38% | 349.76% | 1,076.09% | 0.00% | 225.44 | 38.54 | 35.23 | |
37.40 | 13.55 | 31.5 | 55.02 | 36.21 | 5.38% | -0.21% | -9.88% | 11.64% | 10.49% | 0.00% | 0.00 | 40.57 | -5.02 |
Norris Medicines Share Price FAQs
What is the Mutual Fund shareholding in Norris Medicines ?
The Mutual Fund Shareholding in Norris Medicines was 0.01% at the end of 5/9/2025.
How to buy Norris Medicines shares?
You can easily buy Norris Medicines shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
What is the 52-week high and low of Norris Medicines ?
The 52-week high and low of Norris Medicines share price is ₹27.74 and ₹14.78 as of 5/9/2025.
Please be aware that Norris Medicines stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account